Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Erythroblastic, Acute × entinostat × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 2 Melanoma 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Brain Stem Neoplasms 1 Brain Neoplasms 1

Interventions

Cytarabine 21 fludarabine phosphate 9 Mitoxantrone 8 Busulfan 7 Idarubicin 6 Daunorubicin 6 Whole-Body Irradiation 5 Peripheral Blood Stem Cell Transplantation 5 Methotrexate 5 Gemtuzumab 5 Etoposide 5 alvocidib 4 Vorinostat 4 Filgrastim 4 Cyclosporine 4 Cyclophosphamide 4 Clofarabine 4 Azacitidine 4 Antilymphocyte Serum 4 tipifarnib 3 Tacrolimus 3 Mycophenolic Acid 3 Flow Cytometry 3 Decitabine 3 Bortezomib 3 fludarabine 2 aldesleukin 2 Pravastatin 2 Observation 2 In Situ Hybridization, Fluorescence 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡